Texas Oncology’s radiation oncologists use advanced treatment planning systems and technology tools in the fight against radiation-resistant and recurrent cancer. One of the more specialized tools available is called hyperthermia treatment, which attacks tumors with the additive effects of precisely delivered therapeutic heat.
Researchers have found that elevated temperatures within malignant tumors can disrupt and destroy a cancer cell’s ability to repair DNA damage from radiation. As the cancer cells try to reproduce, they die, and the tumor shrinks. Normal cells recover without long-term damage. Hyperthermia therapy uses heat applied directly to the cells to destroy cancer cells or make them more sensitive to enhance the effects of more conventional treatments, such as chemotherapy and radiation.
Hyperthermia works by a multitude of mechanisms, including:
Hyperthermia therapy is administered by the Pyrexar-500, a powerful microwave system that delivers heat energy directly into the cancerous tumor at temperatures between 104-113 degrees Fahrenheit. This treatment destroys malignant tumor cells while minimizing damage to the surrounding healthy tissue. When used as part of a combined treatment regimen, hyperthermia improves the effectiveness of other cancer treatments, such as radiation and chemotherapy.
Hyperthermia therapy can be delivered locally or regionally.
Hyperthermia treatment technology has been approved by the U.S. Food and Drug Administration to treat malignant tumors on the surface of the body (superficial) or deep in the body (interstitial). Hyperthermia is used for cancers of the skin such as melanoma and squamous and basal cell carcinomas, which may have recurred after conventional treatment. In addition, it is used for select cancers of the rectum, prostate, and cervix. It is covered by most insurances and Medicare.
Sources: American Cancer Society, National Cancer Institute, National Center for Biotechnology Information, and Pyrexar Medical
